Prevention of hearing loss in patients with multidrug-resistant TB

A correspondence published in The Lancet addresses the issue of prevention of hearing loss in patients with multidrug-resistant TB by using newer drugs bedaquiline or delamanid, and repurposed drugs linezolid and clofazimine, instead of an injectable agent.